Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • sjamal
    Junior Member
    • Oct 2019
    • 1

    #1

    How to interpret IGV exon labeling

    Hi,

    My question is related to IGV's transcripts and exon annotation. For RAD51B, position chrr14:68331430:68331691 when I hover over . the exon (labeled by the thick blue bar on IGV) none of the options label an exon number however it does should multiple transcripts. What meaning does this have? I would have . expected that all such would be labeled with a exon number.

    Many thanks for looking into this
    Sabri
  • crisime
    Junior Member
    • Jul 2015
    • 4

    #2
    Hi Sabri,
    I think in your case you only have one exon at this position. But you don't see it because your track is collapsed.
    In IGV most tracks come with three different display options:
    Collapsed
    Expanded
    Squished
    By default tracks are collapsed (you can change this in the preferences).
    Click right on your track and switch to "Expanded" and you will see each transcript visualised seperately. In collapsed you only see all the transcripts merged to one line.

    I hope that helps
    Chris

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Today, 10:35 AM
    0 responses
    3 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-06-2026, 07:41 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    40 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    46 views
    0 reactions
    Last Post SEQadmin2  
    Working...